Article study design/type | N (%) |
---|---|
Commentary or program description | 18 (72%) |
Research with quantitative outcomes | 4 (16%) |
Research with qualitative outcomes | 2 (8%) |
Case report | 1 (4%) |
 Country | |
 United States | 13 (52%) |
 Puerto Rico | 1 (4%) |
 South Africa | 1 (4%) |
 United Kingdom | 1 (4%) |
 Ireland | 1 (4%) |
 India | 2 (8%) |
 Australia | 3 (12%) |
 Canada | 1 (4%) |
 Spain | 1 (4%) |
 Italy | 1 (4%) |
Care setting | |
 Substance use treatment | 13 (52%) |
 Outreach/harm reduction | 7 (28%) |
 Correctional facility | 2 (8%) |
 Mobile clinic | 2 (8%) |
 Primary care/general practitioner | 1 (4%) |
Type of organization | |
 Academic institution | 7 (28%) |
 Government/academic partnership | 3 (12%) |
 Government | 4 (16%) |
 Non-for-profit organization | 3 (12%) |
 Independent clinic | 7 (28%) |
 Commercial laboratory | 1 (4%) |
Services described | |
 OUD Treatment | 21 (84%) |
 Harm reduction | 1 (4%) |
 OUD Treatment and Harm reduction | 3 (12%) |
Types of medications offered | |
 Sublingual buprenorphine | 16 (64%) |
 Extended release buprenorphine | 3 (12%) |
 Methadone | 11 (44%) |
 Extended-release naltrexone | 1 (4%) |
 Naloxone | 12 (48%) |
New vs. modification of program | |
 New | 4 (16%) |
 Modification | 21 (84%) |